We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biotech Temperature Control Products Made from a Novel Thermo-Adaptive Alloy

By LabMedica International staff writers
Posted on 15 Jul 2010
A line of products that standardizes temperature control during manipulation and storage of biological samples is now available for biotechnology investigators.

Thermoconductive "CoolRacks” from BioCision (Mill Valley, CA, USA) are manufactured from a novel patent-pending thermo-adaptive alloy. More...
This material quickly equilibrates all sample wells or chambers to within 0.1 °C of the source temperature. This is true whether the temperature is being cooled by cold water, ice, dry ice, or liquid nitrogen; or whether samples are being warmed by water bath or heating block.

Specimen tubes are kept upright at exactly the same temperature regardless of well position, and racked samples can be moved from ice to water bath en masse, giving a rapid identical temperature shift for all samples. In addition to eliminating temperature variability, CoolRacks provide the investigator with a system for stable, compact, and indexed organization.

CoolRacks are available in a wide range of formats for use with cryo storage tubes, microfuge tubes, PCR strips and plates, and many other consumables. In conjunction with the BioCision "CoolBox,” CoolRacks can also be used for short-term sample transfer or transportation, as the CoolBox maintains the temperature of CoolRack for up to eight hours.

Rolf Ehrhardt, CEO of BioCision, said, "In the context of the worldwide effort to standardize common sample-handling processes. CoolRacks introduce simplicity and reproducibility to a variety of basic research and clinical protocols involving temperature-sensitive biologics, vaccines, RNA, DNA, and enzymes.”

Related Links:
BioCision




New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.